Costanza Falcidia
Pieve Emanuele, 20072, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.
Journal: Dermatology and therapy
Published: May 05, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.
Journal: Dermatology and therapy
Published: April 24, 2026
Dose Adjustment of JAK Inhibitors for the Management of Moderate-to-Severe Atopic Dermatitis: A Single-Centre Retrospective Study.
Journal: Medicina (Kaunas, Lithuania)
Published: April 13, 2026
JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology.
Journal: Medicina (Kaunas, Lithuania)
Published: December 14, 2025
Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study.
Journal: Journal of clinical medicine
Published: August 08, 2025
Real-World Effectiveness and Safety of Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Study.
Journal: Journal of clinical medicine
Published: April 14, 2025
New and Emerging Biologics and Jak Inhibitors for the Treatment of Prurigo Nodularis: A Narrative Review.
Journal: Medicina (Kaunas, Lithuania)
Published: March 07, 2025
Chronic Hand Eczema (CHE): A Narrative Review.
Journal: Dermatology and therapy
Published: December 29, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026